Experimental HIV vaccine shows promise in early safety trial
Disease control
Completed
This early-stage trial tested a therapeutic DNA vaccine called ICVAX in 45 people with HIV who were already stable on antiretroviral therapy (ART). The goal was to see if the vaccine is safe and whether it can boost the immune system to better control the virus. Participants rece…
Phase: PHASE1 • Sponsor: Immuno Cure Holding (HK) Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC